CAMBRIDGE, Mass.--(BW HealthWire)--Feb. 4, 2002--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Merrill Lynch on Tuesday, February 5, 2002 at 4:10pm ET. The webcast may be viewed at http://www.on24.com/clients/merrill/conference_020205/index.html? presenter=richardfpop&format=rmaudio and will remain archived for 30 days.
Senior management will provide an overview of the company at 4:10pm ET on Tuesday, February 5, 2002, from The Grand Hyatt Hotel in New York.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
--30--es/bos*
| CONTACT: | Alkermes, Inc. |
|---|---|
| Rebecca Peterson | |
| (617) 583-6378 | |